IPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets.

Garland, Suzanne M; Bhatla, Neerja; Woo, Yin Ling

Garland, Suzanne M; Bhatla, Neerja; Woo, Yin Ling.

Afiliação

Garland SM; Reproductive & Neonatal Infectious Diseases, Department of Obstetrics and Gynaecology, University of Melbourne, Director Centre Women's Infectious Diseases Research, Honorary Research Fellow, Infection & Immunity, Murdoch Children's Research Institute, Parkville, VIC 3052, Australia. Electronic address: Suzanne.Garland@thewomens.org.au.
Bhatla N; Department of Obstetrics & Gynaecology, Room 3101, Teaching Block, All India Institute of Medical Sciences, New Delhi 110029, India.
Woo YL; Department of Obstetric and Gynaecology, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, W.Persekutuan Kuala Lumpur, Malaysia. Electronic address: ylwoo@ummc.edu.my.

Vaccine ; 42(26): 126400, 2024 Oct 02.

Article em En | MEDLINE | ID: mdl-39366196

ABSTRACT

ABSTRACT

The global supply of human papillomavirus (HPV) prophylactic vaccines has been constrained since 2020.Vaccine manufacturers have increased capacity and new HPV vaccines are now available. Vaccine supply is now able to meet the full HPV vaccine demand which has been achieved earlier than predicted.

Palavras-chave

Human papillomavirus (HPV); Vaccine supply constraint

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vaccine Ano de publicação: 2024 Tipo de documento: Article País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google